News

Top Gainers This Week: Exact Sciences and Other Winners

Top Gainers This Week: Exact Sciences and Other Winners

Overview of Top Gainers

This week showcased impressive performances among several large-cap stocks, making waves in the market. Notably, the standout performers are noteworthy additions to any investor's portfolio. Let's dive in and explore these top gainers.

Exact Sciences Corporation (NASDAQ: EXAS)

Leading the pack, Exact Sciences Corporation gained a remarkable 48.97% this week. The surge followed news that Abbott Laboratories has agreed to acquire the company, valuing the deal at approximately $20 billion with a purchase price of $105 per share. This acquisition reflects increasing confidence in Exact Sciences' innovative cancer diagnostic solutions.

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)

Jazz Pharmaceuticals experienced a solid gain of 3.75% after multiple analysts revised their price targets upward. This revision was spurred by promising phase 3 trial results for its Ziihera combination therapy aimed at treating advanced gastroesophageal cancer. The positive sentiment surrounding this drug's potential played a significant role in bolstering investor confidence.

Natera, Inc. (NASDAQ: NTRA)

Natera also made headlines with a 12.90% increase this week. UBS analyst Elizabeth Garcia maintained a Buy rating on the stock, raising the price forecast from $218 to $280, delighted investors looking to capitalize on Natera's advancements in genetic testing and prenatal screening technologies.

Amer Sports, Inc. (NYSE: AS)

Amer Sports witnessed a substantial 12.86% rise driven by strong third-quarter financial results and elevated FY25 guidance. Analysts are upbeat about the company’s performance, forecasting further growth based on rising sales in unique sporting goods.

James Hardie Industries PLC (NYSE: JHX)

James Hardie Industries posted a commendable 12.39% jump this week. Improved Q2 financial results and the appointment of Ryan Lada as CFO have contributed to heightened investor confidence in the company's future direction.

Guardant Health, Inc. (NASDAQ: GH)

Guardant Health's stock climbed 11.57% this week, reflecting growing investor enthusiasm in the precision oncology sector, indicating potential for significant growth as cancer diagnostics evolve.

Lumentum Holdings Inc. (NASDAQ: LITE)

Lumentum saw a 9.38% increase in its stock this week. The initiation of coverage by Mizuho analyst Vijay Rakesh with an Outperform rating, along with an ambitious price forecast of $290, has generated excitement among investors.

Solventum Corporation (NYSE: SOLV)

Solventum's stock gained 9.09% this week after announcing an acquisition agreement for Acera Surgical. Alongside the acquisition, the board approved a $1 billion stock buyback plan, signaling strong confidence in long-term growth.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

At a steady increase of 9.09%, Regeneron is reaping the benefits of the FDA's recent approval of Eylea HD, which treats macular edema. This regulatory success strengthens its position in the pharmaceuticals market.

Alphabet Inc. (NASDAQ: GOOGL)

Alphabet faced a 4.9% increase as the company addressed concerns regarding a DOJ proposal aimed at restructuring Google Ad Manager. Alphabet's statement indicated that the proposed changes were seen as disruptive, stressing its commitment to finding a resolution beneficial for all stakeholders.

Conclusion

This week's remarkable performances among these large-cap stocks demonstrate a positive trend in the market, characterized by strategic acquisitions, innovative therapies, and solid financial results. Investors should keep an eye on these outperformers as they navigate the complexities of today's market.

Frequently Asked Questions

What are large-cap stocks?

Large-cap stocks are shares of companies with a market capitalization of $10 billion or more, typically considered more stable investments.

Why did Exact Sciences' stock rise so dramatically?

Exact Sciences' stock surged due to Abbott Laboratories agreeing to acquire them for a significant premium, indicating strong confidence in their business model.

What contributed to the increase in Jazz Pharmaceuticals' stock price?

Jazz Pharmaceuticals saw its stock price rise following revised analyst estimates based on positive clinical trial results.

How does FDA approval impact pharmaceutical stocks?

FDA approval often leads to stock price increases as it validates a drug's safety and efficacy, paving the way for higher revenue potential.

What is the significance of a stock buyback plan?

A stock buyback plan signifies a company's confidence in its own growth and results in reducing the number of shares outstanding, potentially increasing shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 82

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 58

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 121

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
AIM Academy Accreditation Signals a Broader Quality Push

Updated Category News Views 50

Early-childhood education does not hand out many clean, easily comparable scorecards, which is precisely why AIM Academy’s new Cognia recognition deserves a closer look. The Alabama provider has earned Cognia Initial Accreditation, while its Pike Road center received Accreditation with Merit after its Initial Accreditation Review. That is not a revenue event, not a...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 0

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
FFR Adds Academic and Commercial Muscle to Its Board

Updated Category News Views 65

Robotics boards can get crowded with lofty nouns fast, and FFR just added another one with some real-world connective tissue behind it. Carolyn Kissane, associate dean at NYU's Center for Global Affairs, has joined as an independent director. The appointment is not a product launch, a contract, or revenue. It is a governance move. Still, in a business trying to weld...

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 35

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
TDH's First-Half Revenue Grew, but Margins Vanished

Updated Category News Views 106

A rental business can add tenants and still march backward, and TDH Holdings just demonstrated the ugly math. For the six months ended June 30, 2026, revenue from continuing operations rose 26.45% to $0.74 million. That is the pleasant number, and it deserves exactly one polite nod. Everything beneath it looks far less comfortable: costs climbed faster than revenue, gross...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 108

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Expanding Scope of Implantable Medical Devices

Updated Category News Views 122

Overview of the Implantable Medical Devices Market The global market for implantable medical devices is witnessing remarkable growth, with projections estimating it to reach approximately USD 176.33 billion by 2034, escalating at a compound annual growth rate (CAGR) of 6.14%. This rise is largely influenced by a steadily increasing prevalence of chronic diseases and an...

Continue Reading
Revolutionizing Home Financing: The Launch of Rate Intelligence

Updated Category News Views 109

Rate's Innovative AI Solution for Mortgage Lending Rate, a pioneer in financial technology, has recently introduced Rate Intelligence—an advanced AI platform that seeks to redefine the mortgage experience for both homebuyers and loan officers. By leveraging cutting-edge technology, Rate is on a mission to enhance efficiency, speed, and accuracy in the home financing...

Continue Reading
Lindahl Reed Secures OASIS+ Contracts to Enhance Services

Updated Category News Views 163

Lindahl Reed Achieves Significant OASIS+ Contract Awards Lindahl Reed, Inc., a prominent player in the technical and scientific services arena, has recently been awarded the One Acquisition Solution for Integrated Services Plus (OASIS+) – 8(a) and Women-Owned Small Business (WOSB) Multi-Agency Contract master contracts. This new development is noteworthy as it allows...

Continue Reading
Safe Bulkers (NYSE: SB) Sees 52-Week Low Amid Market Struggles

Updated Category News Views 334

Safe Bulkers (NYSE: SB) Faces Market Challenges In a challenging environment for investors, Safe Bulkers Inc. (NYSE: SB) has witnessed its stock drop to a 52-week low, currently standing at $3.4. This decline highlights the broader issues prevalent in the shipping sector, where shifts in demand and fluctuating shipping rates have placed pressure on many companies,...

Continue Reading
Emerging Cybersecurity Trends for 2026: AI's Dual Role

Updated Category News Views 280

Understanding 2026: Cybersecurity Predictions and Insights In an era where technology is evolving at a rapid pace, organizations find themselves at a critical juncture. The proliferation of AI poses both unprecedented opportunities and significant threats. Businesses must stay vigilant against a historic wave of DNS exploitation alongside an evolving threat landscape. As...

Continue Reading